Morning Briefing
Summaries of health policy coverage from major news organizations
Awkward Connection: Mylan CEO Is Senator's Daughter
The Washington Post: CEO At Center Of EpiPen Price Hike Controversy Is Sen. Joe Manchin’s Daughter
The growing congressional scrutiny of pharmaceutical giant Mylan over the high cost of EpiPens could prove awkward for Sen. Joe Manchin. The West Virginia Democrat’s daughter, Heather Bresch, is chief executive of the company, which appears to have hiked the price of the epinephrine auto-injector by 400 percent since 2007. The device, which is used to treat severe allergic reactions, now costs more than $600 per dose. (Ho, 8/24)
The New York Times: Awkward Target For Outrage Over EpiPen: A Senator’s Daughter
That connection, reported this week by CQ HealthBeat, is a twist that could prove to be uncomfortable for Mr. Manchin and his Senate colleagues should Ms. Bresch be called to testify about a more than 400 percent increase in the product’s price since Mylan acquired it in 2007. (Huetteman, 8/24)
The Associated Press: Sen. Manchin Mum On EpiPen Hikes By Daughter's Drug Company
U.S. Sen. Joe Manchin remained mum Wednesday as a pharmaceutical company run by his daughter faced mounting criticism for hiking prices on life-saving allergy injection pens. ... His silence contrasted with a growing number of leaders crying foul on the ballooning prices, including fellow senators and the presidential candidate Manchin has endorsed, Hillary Clinton. (Mattise , 8/24)
